Yoon Suk Jung

Efficacy and safety of <scp>CT‐P13</scp>, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study

Yoon Suk Jung, Dong Il Park, Young Ho Kim et al. · Journal of Gastroenterology and Hepatology · 2015 · 176 citations

Pharmacy, Immunology, Pharmacotherapy +15

Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies

Nam Hee Kim, Yoon Suk Jung, Woo Shin Jeong et al. · Intestinal Research · 2017 · 159 citations · Full text

Medicine, Oncology, Surgery +14

Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study

Yoon Suk Jung, Minkyung Han, Sohee Park et al. · Journal of Crohn s and Colitis · 2017 · 117 citations · Full text

Medicine, Biostatistics, Oncology +15

Clinical outcomes and risk factors for technical and clinical failures of self-expandable metal stent insertion for malignant colorectal obstruction

Jin Young Yoon, Yoon Suk Jung, Sung Pil Hong et al. · Gastrointestinal Endoscopy · 2011 · 114 citations · Full text

Medicine, Oncology, Surgery +17

Different risk factors for advanced colorectal neoplasm in young adults

Ji Yeon Kim, Yoon Suk Jung, Jung Ho Park et al. · World Journal of Gastroenterology · 2016 · 93 citations · Full text

Medicine, Oncology, Pathology +16